Skin cancer is the most commonly diagnosed cancer worldwide. However, if detected early, it can be one of the easiest to cure. With this in mind, Derma.plus developed the following study to better understand the geographical and geopolitical factors which make skin cancer incidences more common, and sometimes deadly, in certain regions over others.
Archive | Other Resources
National Comprehensive Cancer Network Guidelines for patients.
This is a complete guide to information and rsource for Cancer patients. The guideline cover a wide spectrum of cancers.
Posted in Patients, Latest News, Of Interest, Other Resources
Immunotherapy Advances in Melanoma
Melanoma care has fortunately undergone a whirlwind of changes over the past several years. Novel immunotherapies are perhaps the most exciting recent development in cancer care because patients can enjoy long-term benefit from these treatments, meaning that they are possibly “cured.”
Posted in Patients, Of Interest, Other Resources
ASCO 2013 – publications
These are the two pappers that came out of the ASCO 2013 conference in Chicago. To download them please follow the link. Safety and Tumour Responses with Lambrolizumab (Anti-PD-1) in Melanoma. Hamid et al. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1305133 Nivolumab plus Ipilimuamab in Advanced Melanoma. Wolchok et al. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1302369
Posted in Melanoma News, MRV Research, Health Professionals, Patients, Latest News, Other Resources
